EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Novel and Established Markers of Cobalamin Deficiency: Complementary or Exclusive Diagnostic Strategies

Jörn Schneede, Per Magne Ueland

Seminars in Vascular Medicine · 01.01.2005 · 5 (02) · 140-155

DOI: 10.1055/s-2005-872399 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Seminars in Vascular Medicine, erschienen am 01.01.2005. Verfasst von Jörn Schneede und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Chemistry, Umeå University, Umeå, Sweden. Die Arbeit wurde bisher 25-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

New developments in diagnostic markers and a better understanding of the limitations of traditional diagnostic strategies have allowed diagnosis of earlier stages and atypical forms of cobalamin deficiency. Still, there are no generally accepted guidelines for the definition, diagnosis, treatment, and follow-up of cobalamin deficiency. The new trend toward defining cobalamin deficiency purely on the basis of biochemical test outcomes in the absence of overt clinical signs and symptoms could, however, be problematic and may result in overdiagnosis and overtreatment. Use of metabolic markers for the assessment of cobalamin deficiency allows the demonstration of tissue deficiency, but the establishment of the cause of deficiency should also be part of the diagnostic approach. Four groups of diagnostic tests are currently available and these include total cobalamin and cobalamin fractions (such as holo-transcobalamin), tests of gastrointestinal dysfunction, tests of metabolic function, and different gene tests. Among the available tests, only homocysteine, methylmalonic acid, holo-transcobalamin, and possibly methylcitric acid are considered to be useful in clinical practice to add to cobalamin. Gastrointestinal function tests may identify the cause of cobalamin deficiency, whereas the diagnostic usefulness of genetic testing needs to be evaluated. This article provides an overview of recent developments and a reappraisal of novel and established diagnostic markers for cobalamin deficiency.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersDiagnosis, DifferentialHomocysteineHumansMethylmalonic AcidTranscobalaminsVitamin B 12Vitamin B 12 Deficiency

Substanzen

BiomarkersTranscobalaminsHomocysteineMethylmalonic AcidVitamin B 12

Autor:innen und Institutionen

  • Department of Clinical Chemistry, Umeå University, Umeå, Sweden.

Zitieren

APA

Schneede, J., & Ueland, P. M. (2005). Novel and Established Markers of Cobalamin Deficiency: Complementary or Exclusive Diagnostic Strategies. Seminars in Vascular Medicine, 5(02), 140-155. https://doi.org/10.1055/s-2005-872399

Vancouver

Schneede J, Ueland PM. Novel and Established Markers of Cobalamin Deficiency: Complementary or Exclusive Diagnostic Strategies. Seminars in Vascular Medicine. 2005;5(02):140-155. doi:10.1055/s-2005-872399

BibTeX
@article{Schneede2005,
  author = {Schneede, Jörn and Ueland, Per Magne},
  title = {Novel and Established Markers of Cobalamin Deficiency: Complementary or Exclusive Diagnostic Strategies},
  journal = {Seminars in Vascular Medicine},
  year = {2005},
  volume = {5},
  number = {02},
  pages = {140--155},
  doi = {10.1055/s-2005-872399}
}
Kostenlos starten →